Stated plainly: ERP · a GLP-1 receptor agonist.
I have read the primary source rather than the summary, which has left me with more questions.
I understand the headline. I do not understand the footnotes, and the footnotes look important.
What can I legitimately conclude from this figure?
A useful certificate has five elements: the lot number, the analytical method, the reported result with units, the date of analysis, and the primary data or a reference to it.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
| Test | Answers | Does NOT answer |
|---|---|---|
| RP-HPLC, area % | What fraction of detected material is the target | How much target is present |
| Quantified content | Milligrams of peptide per vial | What the impurities are |
| ESI-MS identity | Whether the molecular weight matches | Purity, or isomeric substitution |
| Peptide mapping | Sequence, localised to a fragment | Quantity |
| Karl Fischer | Water content of the solid | Solvent content |
| LAL endotoxin | Pyrogen load in EU/mg | Sterility |
| Sterility test | Growth in defined media over 14 days | Endotoxin, or bioburden count |
Concretely, the certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.
One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsWorth being precise here: the certificate is not the answer to your question; it is a data point that you need to combine with other information to build an answer.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
On the detail: a method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
To be exact about it, what makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.
The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
Worth being precise here: multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
If the certificate does not trace to your vial, it is not evidence about your vial.
The underlying point is that a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
My working rule is that a document without a lot number, a method section and a test date is marketing.
edited 9 Dec 2025 by lyoph_cake — reworded for clarity after a comment
Start from what the certificate claims to measure and what the claimed measurement actually answers, because those are two different questions.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.